Gandhewar, Rishikesh
Guimaraes, Thales
Sen, Sagnik
Pontikos, Nikolas
Moghul, Ismail
Empeslidis, Theodoros
Michaelides, Michel
Balaskas, Konstantinos https://orcid.org/0000-0002-7690-6277
Article History
Received: 12 February 2025
Revised: 17 February 2025
Accepted: 23 February 2025
First Online: 10 March 2025
Declarations
:
: Not applicable.
: Nikolas Pontikos is the non-salaried co-founder and director of Phenopolis Ltd. Ismail Moghul has equity in READ AI Konstantinos Balaskas has equity in READ AI received speaker fees from Novartis, Bayer, Alimera, Allergan, Roche, and Heidelberg; meeting or travel fees from Novartis, Bayer and Boehringer-Ingelheim; compensation for being on an advisory board from Novartis, Bayer and Apellis; consulting fees from Novartis, Roche and Google; and research support from Apellis, Novartis, and Bayer. All other authors declare no relevant conflicts of interest.
: This article does not contain any studies with humans or animals performed by any of the authors.